Central Pharmaceuticals Ltd. Stock

Equities

CENTRALPHL

BD0487CPL007

End-of-day quote Dhaka S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
22 BDT -0.90% Intraday chart for Central Pharmaceuticals Ltd. -0.90% +8.91%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 26M 224K Sales 2023 29.33M 253K Capitalization 1.49B 12.81M
Net income 2022 -68M -586K Net income 2023 -44M -379K EV / Sales 2022 70.6 x
Net Debt 2022 267M 2.3M Net Debt 2023 267M 2.3M EV / Sales 2023 59.8 x
P/E ratio 2022
-23 x
P/E ratio 2023
-33.8 x
Employees 74
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Central Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2020 CI
Central Pharmaceuticals Ltd. Restates Earnings Results for the Period from January-March 2020 and for the Period from July 2019-March 2020 CI
Central Pharmaceuticals Ltd. Recommends 1% Cash Dividend for the Year Ended on June 30, 2019 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2019 CI
CENTRALPHL Announces Demise of Nashima Akhter, Director on May 18, 2018 CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018 CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017 CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 2017 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2017 CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
More news
1 day-0.90%
1 week-0.90%
Current month-3.08%
1 month-19.71%
3 months-25.68%
6 months+56.03%
Current year+8.91%
More quotes
1 week
21.80
Extreme 21.8
24.60
1 month
21.20
Extreme 21.2
27.90
Current year
16.00
Extreme 16
35.60
1 year
10.40
Extreme 10.4
35.60
3 years
9.90
Extreme 9.9
35.60
5 years
6.60
Extreme 6.6
35.60
10 years
6.60
Extreme 6.6
35.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 98-12-19
Director of Finance/CFO - -
Chairman 49 07-07-15
Members of the board TitleAgeSince
Chairman 49 07-07-15
Chief Executive Officer 57 98-12-19
Director/Board Member - -
More insiders
Date Price Change Volume
24-05-09 22 -0.90% 3,859,935
24-05-08 22.2 -2.63% 3,334,826
24-05-07 22.8 -2.98% 5,044,737
24-05-06 23.5 +1.29% 5,000,705
24-05-05 23.2 +4.50% 3,939,276

End-of-day quote Dhaka S.E., May 08, 2024

More quotes
  1. Stock Market
  2. Equities
  3. CENTRALPHL Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW